Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 328 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fetal Complications Clear all

Conditions: Urethral Obstruction
Interventions: Fetal Intervention for LUTO; Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 11 Weeks to 2 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: CARRII, CARRII Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Fetal Growth Retardation
Interventions: Ultrasound following the SMFM guidelines, Ultrasound following the ISUOG guidelines; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Not listed
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chorioamnionitis
Interventions: Type of glove used for intrapartum vaginal exams; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 507 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities, Microdeletion Syndromes
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,059 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 7
States / cities: San Carlos, California • San Gabriel, California • Washington D.C., District of Columbia + 4 more

Conditions: Perinatal Depression
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: Rana Jawish; Other
Eligibility: 22 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pregnancy Complications
Interventions: Not listed
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Pregnancy Related, Food Insecurity, Premature Birth, Pregnancy Complications
Interventions: Food Delivery, Financial Support; Behavioral · Other
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Fetal Membranes, Premature Rupture, Labor, Induced/IS
Interventions: Transcervical Foley catheter; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 12 Years to 55 Years · Female only
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 3
States / cities: Birmingham, Alabama • Newark, Delaware • Greenville, South Carolina

Conditions: Fetal Conditions, Maternal; Procedure, Pregnancy Related, Twin to Twin Transfusion Syndrome, In Utero Procedure Affecting Fetus or Newborn, Chorion; Abnormal, Twin Reversal Arterial Perfusion Syndrome, Twin Monochorionic Monoamniotic Placenta, Chorioangioma, Vasa Previa
Interventions: Karl Storz Curved Scope, Karl Storz Straight Scope; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gestational Diabetes
Interventions: Choline supplement, Placebo; Dietary Supplement
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Diabetes, Gestational
Interventions: nutritional counseling, self blood glucose monitoring; Behavioral
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 7,381 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2013
U.S. locations: 16
States / cities: Birmingham, Alabama • Chicago, Illinois • Detroit, Michigan + 13 more

Conditions: Grief, Post Traumatic Stress Disorder, Suicidal Ideation, Miscarriage, Stillbirth, Infant Death
Interventions: Along With Me, Peer Guide; Behavioral
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: 15 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Eugene, Oregon • Springfield, Oregon

Conditions: Music Therapy, Preterm Premature Rupture of Membrane (PPROM)
Interventions: Music Therapy Intervention; Behavioral
Lead sponsor: Christina Chianis Reed; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth
Interventions: Ceftriaxone 1000 MG, Clarithromycin 500mg, Metronidazole 500 mg, Ampicillin 2 GM Injection, Amoxicillin 250 MG, Azithromycin, Erythromycin; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Columbus, Ohio • Galveston, Texas

Conditions: Pregnancy, Gestational Diabetes, Type 2 Diabetes
Interventions: Group prenatal care; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Denver, Colorado • St Louis, Missouri

Conditions: Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 4
States / cities: Boston, Massachusetts • Glen Cove, New York • New York, New York + 1 more

Conditions: Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome
Interventions: Not listed
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Chorioamnionitis
Interventions: Unasyn, Ampicillin/gentamicin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: Choline Bitartrate; Drug
Lead sponsor: Jeff Wozniak; Other
Eligibility: 30 Months to 72 Months
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Fetal Alcohol Syndrome, Teen Pregnancy
Interventions: An educational video about Fetal Alcohol Syndrome; Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 12 Years to 16 Years · Female only
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Maternal; Chorioamnionitis, Affecting Fetus, Early-Onset Sepses, Neonatal
Interventions: EOS Calculator; Diagnostic Test
Lead sponsor: Pediatrix; Other
Eligibility: 35 Weeks and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Obesity, Induction of Labor Affected Fetus / Newborn
Interventions: Cefazolin, Placebo, Azithromycin; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Premature Rupture of Membrane, Induction of Labor Affected Fetus / Newborn
Interventions: Misoprostol Oral Product, Intravenous Oxytocin; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Standardized Prenatal Clinical Care for LUTO

Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial

Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation

Intrapartum Study of Sterile and Clean Gloves

Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

Transcranial Magnetic Therapy (TMS) for Treatment of Perinatal Depression

Prenatal Sonographic Prediction of Placental Histology and Function

Nourishing Beginnings: Addressing Food Insecurity During Pregnancy

Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture

A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus

Gestational Diabetes Mellitus Trial (GDM)

Walk With Me (WWM) for Perinatal Grief

Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Diabetes Group Prenatal Care

High Risk Multiple Gestation Study

Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies

Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

PROMMO Trial: Oral Misoprostol vs IV Oxytocin